Corvex Management’s Pfizer PFE Stock Holding History

Corvex Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-18,486,216	Closed	-$520M	–	37
2016 Q1	$520M	Buy	18,486,216 +5,401,493	+41%	+$154M	8.59%	5
2015 Q4	$401M	Buy	13,084,723 +12,753,503	+3,850%	+$401M	5.34%	7
2015 Q3	$9.87M	Buy	+331,220	New	+$10.6M	0.12%	33

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Corvex Management's PFE Position: Q2 2016 in Review

Corvex Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 18,486,216 shares — an estimated $520M sold.

Corvex Management first reported a position in PFE in Q3 2015 and held it in 3 quarters. The position peaked at $520M in Q1 2016. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Corvex Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Corvex Management sold 18,486,216 Pfizer shares in Q2 2016, an estimated $520M.
Corvex Management first reported a position in Pfizer in Q3 2015 and held it in 3 quarters.
Corvex Management's Pfizer position peaked at $520M in Q1 2016.
1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Corvex Management's 13F filing for Q2 2016, filed 15 Aug 2016.